Mira Pharmaceuticals (MIRA) Other Accumulated Expenses (2022 - 2025)

Mira Pharmaceuticals has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $572865.0 for Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $572865.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $572865.0 (changed N/A YoY), and the FY2025 annual result was $572865.0, changed N/A from the prior year.
• Other Accumulated Expenses came in at $572865.0 for Q4 2025 at Mira Pharmaceuticals, up from $14592.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $572865.0 in Q4 2025 to a low of $14592.0 in Q3 2023.
• The 3-year median for Other Accumulated Expenses is $22534.0 (2022), against an average of $203330.3.